1 THE 4 th ISRAELI NEUROENDOCRINE TUMORS (INET) CONGRESS 11.10.2018-13.10.2018 Crown Plaza Hotel, the Dead Sea PROGRAM Thursday, 11.10.2018 15:00-15:30 Registration 15:30-15:50 Opening Remarks: Dr. Simona Glasberg, Dr. Asher Salmon 15:50-16:50 Symposium: Update in Immunotherapy in NETs and beyond Chair: Prof. Ido Wolf & Prof. Salomon Stemmer 15:50-16:10 Any Role for Immunotherapy in NETs - Where are we now? Dr. Ravit Geva, Oncology Division, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel 16:10-16:30 Swinging Between Immunotherapy and Hormones Dr. Roni Shapira, Department of Oncology, Sheba Medical Center, Israel 16:30-16:50 Adaptive Cell Therapy in Cancer Prof. Michal Lotem, Hadassah Center for Melanoma and Immunotherapy, the Hebrew University-Hadassah Medical School, Jerusalem, Israel. 16:50-17:30 Plenary Lecture: Hormonal Hypersecretion Syndromes in NETs: New Avenues in Their Treatment and Prognosis Significance Chair: Dr. Simona Glasberg Speaker: Prof. Wouter De Herder, Section Endocrinology, ENETS Centre of Excellence for Neuroendocrine Tumours, Erasmus University Medical Center and Erasmus MC Cancer Institute, Rotterdam, The Netherlands 1
2 17:30-17:50 Coffee Break 17:50-18:50 Symposium: Controversies in the Surgical Approach in NETs Chair: Dr. Abed Khalaileh & Dr. David Hazzan 17:50-18:20 Primary Tumor Excision in Metastatic SI NETs. Pro: Prof. Haggi Mazeh, Department of Surgery, Hadassah Con: Prof. Petachia Reissman, Department of Surgery, Shaare Zedek Medical Center, Jerusalem, Israel 18:20-18:50 Primary Tumor Excision in Metastatic PNETs. Pro: Dr. Ido Nachmani, Department of Surgery, Surasky Medical Center, Tel Aviv, Israel Con: Dr. Abed Khalaileh, Department of Surgery, Hadassah 19:30 Dinner 21:00 Get Together 2
3 Friday, 12.10.2018 8:30-9:30 Plenary Lecture: "Update in the Pathology of NETs - Where We Are Now" Chair: Dr. Judith Diment & Dr. Gratiana Hermann Speaker: Prof. Guido Rindi, Università Cattolica-Policlinico A.Gemelli, Rome, Italy 9:30-10:30 Symposium: Advances in Loco-regional Strategies in NETs Chair: David J. Gross & Prof. Yodphat Krausz 9:30-9:50 Update in the Loco-regional Therapies for Liver Metastases in NETs. Prof. Allan Bloom, Department of Interventional Radiology, Hadassah-Hebrew 9:50-10:10 New GI Endoscopic Therapies in the Treatment of Neuroendocrine Tumors. Dr. Harold Jacob, Advanced Endoscopy Unit, Hadassah University Medical Center Ein Karem, Jerusalem, Israel 10:10-10:30 Is There Any Role for Brachytherapy in Lung NETs? Dr. Amichay Meirovitz, Sharett Institute of Oncology, Hadassah 10:30-10:50 Coffee Break 10:50-11:30 Plenary Lecture: "Signaling Networks in Neuroendocrine Lung Cancer" Chair: Dr. Asher Salmon Speaker: Prof. Julien Sage, Departments of Pediatrics and Genetics, Stanford University, USA 11:30-12:35 Symposium: Unusual NETs Chair: Dr. Einat Shacham-Shmueli 11:30-11:45 Prostate Carcinoma - What Neuroendocrine Features Mean? Dr. Raanan Berger, Department of Oncology, Sheba Medical Center, Israel 11:45-12:10 Merkel Cell Carcinoma An Update Dr. Asher Salmon, Sharett Institute of Oncology, Hadassah 12:10-12:35 NETs of Unusual Origin Dr. Ophra Maimon, Sharett Institute of Oncology, Hadassah 12:35-14:00 Lunch 3
4 14:00-15:30 Workshop Complex NETs Cases Speakers: Dr. Ety Osher, Institute of Endocrinology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel; Dr. Kira Oleinikov, NET Unit, Hadassah ; Dr. Rahel Rosenbloom, Endocrinology Unit, Meir Medical Center, Kfar-Saba, Israel Panel: Prof. Wouter De Herder, Prof. Guido Rindi, Dr. Simona Glasberg, Prof. David J. Gross, Prof. Ido Wolf, Dr. Amichay Meirovitz, Dr. Asher Salmon. 15:30-15:40 Closing Remarks: Dr. Simona Glasberg, Dr. Amichay Meirovitz 19:00 Dinner 21:00 Get Together Saturday, 13.10.2018 07:00-09:00 Breakfast 11:00-12:00 Lecture - TBA 13:00-15:00 Lunch 16:00 Check out (Saturday evening for religious participants) Organizing committee Chair: Dr. S. Glasberg, Neuroendocrine Tumor Unit, Hadassah Hebrew University Medical Center, Jerusalem, Israel; simonag@hadassah.org.il Secretary: Dr. A. Salmon, Dr. Ofra Maimon, Dr. A. Meirovitz, Sharett Institute of Oncology, Hadassah Hebrew ; ASalmon@hadassah.org.il; AmichayM@hadassah.org.il Scientific committee: Dr. S. Glasberg, Neuroendocrine Tumor Unit, Hadassah Hebrew ; simonag@hadassah.org.il; Prof. I. Wolf, Oncology Division, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel idow@tlvmc.gov.il; Prof. David Gross, Neuroendocrine Tumor Unit, Hadassah Hebrew ; gross@vms.huji.ac.il; 4
5 Sponsors: Platinum Sponsor: Novartis Oncology Gold Sponsors: Medison Pharma Silver Sonsors: Sanofi Pfizer Abbie Educational Grants: Israel Endocrine Society Israel Cancer Association 5